Custom Pharma Services

Executive Summary

Custom Pharma Services is a UK-based contract development and manufacturing organization (CDMO) specializing in oral solid dose forms, including tablets, capsules, caplets, and powders. Founded in 2005, the company operates from an MHRA-approved facility and focuses on high-quality, compliant manufacturing for niche areas such as controlled drugs and hormonal products. Its emphasis on client partnership and regulatory expertise positions it well within the growing CDMO market, particularly as pharmaceutical companies increasingly outsource complex manufacturing. With a strong track record in commercial production and packaging, Custom Pharma Services serves as a reliable partner for both small and large pharma firms seeking specialized oral solid dose capabilities. The company's private status and dedicated facility support its ability to maintain high standards and responsiveness in a competitive landscape. The outlook for Custom Pharma Services is positive, driven by the steady demand for oral solid dose manufacturing and the trend toward outsourcing by pharmaceutical companies. The company's niche focus on controlled substances and hormonal products provides differentiation and barriers to entry. Key growth drivers include potential capacity expansions, new client contracts, and expansion into adjacent dosage forms or services. While the company operates in a mature market, its specialized expertise and regulatory compliance offer a sustainable competitive advantage. The lack of recent funding or M&A activity suggests a focus on organic growth, which could limit the pace of expansion but supports stable operations.

Upcoming Catalysts (preview)

• Q3 2026New Capacity Expansion or Facility Upgrade60% success
• TBDMajor New Client Contract for Controlled Drugs50% success
• TBDExpansion into New Dosage Forms or Services40% success